Radiation Therapy Following Surgery to Remove Brain Metastases
Metastatic Cancer
About this trial
This is an interventional treatment trial for Metastatic Cancer focused on measuring tumors metastatic to brain
Eligibility Criteria
Inclusion Criteria: Histologically confirmed cerebral metastases post surgical resection No greater than 3 cerebral metastases postresection Gross resection at operation as documented in operation note and postoperative MRI Patients must have current surgical sites that have not been previously irradiated No other indication for whole brain irradiation (i.e., multiple untreated metastases not suitable for single fraction stereotactic radiotherapy, leptomeningeal disease) Age: 18 and over Karnofsky 60-100% Life expectancy: At least 3 months Prior or concurrent required steroids allowed Prior stereotactic radiotherapy of cerebral metastases allowed provided no prior irradiation of current surgical sites Prior surgery of cerebral metastases allowed Exclusion Criteria: severe asthma requiring therapy allergy to iodine or contrast media pregnant concurrent chemotherapy prior whole brain irradiation or focal irradiation to current sites of disease
Sites / Locations
- Jonsson Comprehensive Cancer Center, UCLA